All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
ISO / IsoPlexis Corp
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
CUTRQ / Cutera, Inc.
|
|
|
|
|
|
|
|
RACB / Research Alliance Corp II - Class A
|
|
|
|
|
|
|
|
FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
MDXG / MiMedx Group, Inc.
|
|
|
|
|
|
|
|
SMFR / Sema4 Holdings Corp - Class A
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
PRCT / PROCEPT BioRobotics Corporation
|
|
|
|
|
|
|
|
OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
RXST / RxSight, Inc.
|
|
|
|
|
|
|
|
DNAY / Codex DNA Inc
|
|
|
|
|
|
|
|
ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
AADI / Aadi Bioscience, Inc.
|
|
|
|
|
|
|
|
NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
SOPH / SOPHiA GENETICS SA
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
SUMMIT HEALTHCRE ACQUISTN CO
/ UNIT 06/03/2026 (G8566R128) |
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
INMD / InMode Ltd.
|
|
|
|
|
|
|
|
612657106 / Montes Archimedes Acquisition Corp., Class A
|
|
|
|
|
|
|
|
PROF / Profound Medical Corp.
|
|
|
|
|
|
|
|
KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
UTRS / Minerva Surgical, Inc.
|
|
|
|
|
|
|
|
/ VENTYX BIOSCIENCES INC
|
|
|
|
|
|
|
|
/ Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
AFIB / Acutus Medical, Inc.
|
|
|
|
|
|
|
|
CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
BLI / Berkeley Lights Inc
|
|
|
|
|
|
|
|
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
PNT / POINT Biopharma Global Inc.
|
|
|
|
|
|
|
|
XGN / Exagen Inc.
|
|
|
|
|
|
|
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
|
|
|
|
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
SPY / SPDR S&P 500 ETF
|
|
|
|
|
|
|
|
HLXA / Helix Acquisition Corp - Class A
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
APVO / Aptevo Therapeutics Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
QTRX / Quanterix Corporation
|
|
|
|
|
|
|
|
ZY / Zymergen Inc
|
|
|
|
|
|
|
|
INKT / MiNK Therapeutics, Inc.
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MXCT / MaxCyte, Inc.
|
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
RCEL / AVITA Medical, Inc.
|
|
|
|
|
|
|
|
JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
SGHT / Sight Sciences, Inc.
|
|
|
|
|
|
|
|
RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
LABP / Landos Biopharma, Inc.
|
|
|
|
|
|
|
|
DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
MIRO / Miromatrix Medical Inc
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
AKYA / Akoya Biosciences, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
GHRS / GH Research PLC
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|